Craft

Generate Biomedicines

Generate Biomedicines Summary

Company Summary

Overview
Generate Biomedicines is a therapeutic development company. It develops a machine learning powered drug discovery platform for generating medicines, including antibodies, peptides, enzymes, and stealth proteins. The company focuses on drugs for treating severe asthma, atopic dermatitis, ulcerative colitis, solid tumors, and other diseases.
Type
Public
Status
Active
Founded
2018
HQ
Somerville, MA, US | view all locations
Website
https://generatebiomedicines.com/
Cybersecurity rating
Sectors

Key People

  • Michael Nally

    Michael Nally, Chief Executive Officer

    • Adam Root

      Adam Root, Vice President of Protein Sciences

    • Jake Feala

      Jake Feala, Head of Computational Biology

    • Geoffrey Von Maltzahn

      Geoffrey Von Maltzahn, Co-Founder and Director

      LocationsView all

      1 location detected

      • Somerville, MA HQ

        United States

        101 South St #900

      Generate Biomedicines Financials

      Summary Financials

      Revenue (Q1, 2026)
      $7.2M
      Net income (Q1, 2026)
      ($61.7M)
      Cash (Q1, 2026)
      $160.6M
      EBIT (Q1, 2026)
      ($64.1M)

      Footer menu